Risk Stratification Cohorting

2026-11-03

The NHSE Cohorting (formerly known as Risk Stratification) programme has created tools which will help clinicians and the public to understand an individuals' risk of Covid-19 as well as deploying recently approved therapeutic treatments. Using functionality and infrastructure developed for Covid-19 the Cohorting delivery team within the NHSE Platforms Directorate are also developing a 'Cohorting as a service' function which will underpin strategic initiatives such as Covid Vaccination and Screening Therapeutics. This service will deliver consistent, clinically assured, timely and cost efficient cohorting for the NHS, whilst also helping to lay the groundwork for the delivery of future goals of the NHS such as personalised healthcare and preventative medicine.The Initial Contract Value is £25,600,000 (£32,000,000 including the optional extension period).VARIATIONThe value of this variation is £12,800,000. This variation is being made in accordance with Regulation 72(1)(b) of the Public Contract Regulations 2015.The scope of services provided under the contract remain the same, with the variation facilitating a continuation of support while a re-procurement and transition to a new agreement continues. The Total Contract Value is £44,800,000.

United Kingdom (UK)

2026-05-19